Lung Cancer remains the leading cause of cancer-related deaths worldwide. A recent clinical trial has shown promising results in lung cancer patients. Amgen AMGN has announced positive results from a phase III…
Category: Lung Cancer Drugs
Get an ideas about the lung cancer treatment drugs, here we provide only information about drugs not to advice them to take without proper doctor guideline. For information about lung cancer drugs browse.
Pancreatic Cancer Drug Show Promising Results in Lung Cancer
According to the American Cancer Society, the odds that a person will develop lung cancer is about 1 in 19. Also, more than ¾ of all lung cancers are non-small cell lung…
HARMONi-6 Demonstrates Significant Overall Survival Benefits Among NSCLC Patients
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. In the Phase III HARMONi-6 study, ivonescimab has achieved significant and clinically meaningful improvement in overall survival as a…
Jazz Pharmaceuticals Drug Fails in Phase 3 Lung Cancer Test
Jazz Pharmaceuticals has updated that its lung cancer drug, Zepzelca, failed to meet the goal of improving overall survival in a late-stage study. The company has shared the trial results with U.S….
Merck-Kelun Lung Cancer Drug Outperforms Keytruda in Trial
According to Phase 3 study results, Merck-Kelun combo can reduce the risk of tumor progression by 65% in patients with lung cancer. The study has been conducted in China and is the…
India’s First 7-Minute NSCLC Shot Launched Costing ₹3.7 Lakh Per Dose
India has taken a major step towards lung cancer treatment with launch of a new seven-minute NSCLC injection. Roche Pharma India has introduced a new drug called Tecentriq and is designed to…
Markey Cancer Center Treats First US Patient with Alveltamig for Small Cell Lung Cancer
The University of Kentucky Markey Cancer Center has treated the first patient in US with a new immunotherapy for lung cancer. UK Markey Cancer Center becomes the first site in the country…
Sevabertinib Receive Accelerated Approval by FDA for Non-Squamous NSCLC
Lung cancer is one of the deadly disease responsible for many deaths all around the world. US Food and Drug Administration (FDA) has granted accelerated approval to Sevabertinib (Hyrnuo Bayer HealthCare Pharmaceuticals…